PURE Bioscience, Inc.
PURE
$0.05
$0.001.17%
OTC PK
| 07/31/2025 | 04/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 55.60% | 25.58% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 55.60% | 25.58% | |||
| Cost of Revenue | 42.31% | 26.83% | |||
| Gross Profit | 65.37% | 24.67% | |||
| SG&A Expenses | -5.80% | -10.91% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.33% | -3.67% | |||
| Operating Income | 42.47% | 19.45% | |||
| Income Before Tax | 42.76% | 27.32% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 42.76% | 27.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 42.76% | 27.32% | |||
| EBIT | 42.47% | 19.45% | |||
| EBITDA | 42.37% | 19.53% | |||
| EPS Basic | 42.31% | 26.76% | |||
| Normalized Basic EPS | 40.63% | 28.89% | |||
| EPS Diluted | 42.31% | 26.76% | |||
| Normalized Diluted EPS | 40.63% | 28.89% | |||
| Average Basic Shares Outstanding | 0.02% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.02% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||